Three out of four independent studies demonstrated a clear trend (significant association) toward longer overall survival in ER-negative patients who tested positive for FOXA1 protein expression (Chen, 2021; Dai, 2019; Albergaria, 2009).
← all excerpts
Prognostic value of FOXA1 in estrogen receptor-negative breast cancer: A systematic review and meta-analysis.
1
—
—